Plasma Is Stronger than Blood - What to Expect in Blood-Related Device, Diagnostic and Biopharma Markets

Sustaining several blood-related market segments has been fast-rising demand for source plasma (not collected from whole blood) and plasma-derived products. Data from the Plasma Protein Therapeutics Association indicates that total plasma collected worldwide (source and recovered from donated blood) increased by roughly 9% on average annually between 2008 and 2012. Source plasma – collected with machines that separate and transfuse red blood cells back into the donor (apheresis) – rose by 11% on average each year over the same period. Kalorama Information expects plasma collection to continue to outpace overall blood collection through 2018. The primary market driver will be plasma-derived immunoglobulins (Ig) used to produce intravenous immunoglobulin (IVIG) therapies – Kalorama Information expects the plasma Ig market to grow by over 6% annually through 2018.

Sleep Apnea Far From Slumbering Factor in the Respiratory Device Market

Respiratory health in populations worldwide has been challenged by numerous factors including worsening air quality, substandard living conditions, other allergenic risk factors, and even economic development. Asthma and chronic obstructive pulmonary disorder (COPD) have been significant factors fueling contemporary market growth in the global respiratory devices market according to Kalorama Information.

Physician Office Lab Market Gets a Shot in the Arm: Newly CLIA-Waived Alere i Molecular Flu Test

Rapid influenza (flu) testing is a high-profile fixture of the physician office laboratory (POL) diagnostics market. Easy-to-use lateral flow tests and other immunoassays run on automated readers are adequately reliable for primary care, urgent care and inpatient care settings. Such products also push infectious disease testing into the point-of-care (POC) and near-patient testing arena, allowing providers to initiate care during the same visit or day.

Companion Animal and Food Animal Diagnostics Demand Different Strategies from Vet Dx Companies

With the significant role of in-clinic analyzers, non-infectious disease testing - led by chemistry and hematology - now represents approximately 75% of the companion animal diagnostics market. Infectious disease testing is critical to mitigating overall production loss by preventing disease spread. Immunodiagnostics and molecular diagnostic test kits and reagents account for over 80% of the food animal diagnostics market.

Healthcare IT News On Kalorama Top 5 Trends

Healthcare IT News featured Kalorama's five top healthcare trends of 2014 in its Dec. 30th edition, taking special note of the growth of patient monitoring systems that Kalorama Information projects over the next five years.  The trend analysis we issued for last year is based on the markets we've studied and the requests we've received from customers as areas they'd like to have greater insight into..


Subscribe to Kalorama Information Home RSS